Best of Lipid Forum 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

1.25 CME
0 MINS
$0 FEE
SAVE

Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.

Support Statement: This activity is supported by an educational grant from Amgen.

Target Audience: The intended audience for this activity is primary care physicians, cardiologists, endocrinologists, and other health care professionals involved in the treatment of patients with dyslipidemia.

Learning Objectives: Upon successful completion of this educational series, participants should be better able to:

  • Utilize appropriate risk assessment tools to identify patients on maximally tolerated statin therapy who may benefit from further reduction in LDL-C.
  • Select non-statin agents for patients who have not achieved their LDL goals on statin therapy in accordance with the latest clinical evidence and guidelines.
  • Evaluate the latest clinical data regarding safety and efficacy of achieving very low LDL-C targets, including the impact on cardiovascular outcomes and the need for additional studies. 
  • Assess the latest clinical evidence regarding the impact of non–LDL-C lipids on cardiovascular risk and methods to control the level of these markers. 
  • Analyze current theories and clinical data regarding the association and significance of hyperlipidemia in patients with diabetes and management strategies under investigation.
  • Examine methodologies that may improve access to PCSK9 inhibitors in real-world practice to improve outcomes in patients who qualify for their use.

Activity Chair:
James A. Underberg, FACPM, FACP, FASH, FNLA 
Lipidology & Cardiovascular Disease Prevention 
Clinical Assistant Professor of Medicine 
NYU Medical School & NYU Center for CV Prevention 
Director, Bellevue Hospital Lipid Clinic 
New York, NY 

Faculty:
Michael J. Blaha, MD, MPH
Director of Clinical Research
Ciccarone Center for the Prevention of Heart Disease 
Associate Professor of Medicine 
Johns Hopkins Medicine 
Baltimore, MD

Michael Miller, MD, FACC, FAHA
Professor of Cardiovascular Medicine, Epidemiology & Public Health 
University of Maryland School of Medicine 
Director, Center for Preventive Cardiology 
University of Maryland Medical Center 
Cardiology Division 
Baltimore, MD

Marc S. Sabatine, MD, MPH
Chair, TIMI Study Group
Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine
Brigham and Women's Hospital 
Professor of Medicine 
Harvard Medical School 
Boston, MA 

Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 9, 2018 to March 8, 2019.

How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 5 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty members report the following relationships:
James A. Underberg, FACPM, FACP, FASH, FNLA
Consulting Fee: Amarin, Amgen 
Speakers Bureau:
Alexion, Amarin, Amgen, Kastle, Regeneron, Sanofi, True Health Diagnostics 
Contracted Research:
Aegerion, Pfizer
Advisory Boards:
Akcea, Amgen, Invitae, Kastle, Regeneron, Sanofi

Michael J. Blaha, MD, MPH
Consulting Fee (Advisory Boards): Akcea, Amgen, MedImmune, Novartis, Regeneron, Sanofi 
Contracted Research: Aetna, Amgen

Michael Miller, MD, FACC, FAHA
Consulting Fee: Pfizer
Contracted Research: Amgen

Marc S. Sabatine, MD, MPH
Consulting Fee: Amgen, Bristol-Myers Squibb, CVS Caremark, Esperion, Intarcia, Janssen, MedImmune, Merck, Novartis 
Contracted Research (grants through Brigham and Women's Hospital): Amgen, AstraZeneca, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen, Medicines Company, MedImmune, Merck, Novartis, Pfizer, Poxel, Takeda

Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationship to disclose.

Vindico Medical Education staff report the following relationship(s):
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?
Contact us at cme@vindicoCME.com